Zobrazeno 1 - 10
of 383
pro vyhledávání: '"Anders, Österborg"'
Autor:
Puran Chen, Peter Bergman, Ola Blennow, Lotta Hansson, Stephan Mielke, Piotr Nowak, Yu Gao, Gunnar Söderdahl, Anders Österborg, C.I.Edvard Smith, Jan Vesterbacka, David Wullimann, Angelica Cuapio, Mira Akber, Gordana Bogdanovic, Sandra Muschiol, Mikael Åberg, Karin Loré, Margaret Sällberg Chen, Per Ljungman, Marcus Buggert, Soo Aleman, Hans-Gustaf Ljunggren
Publikováno v:
EBioMedicine, Vol 109, Iss , Pp 105385- (2024)
Summary: Background: Immunocompromised patients with primary and secondary immunodeficiencies have shown impaired responses to SARS-CoV-2 mRNA vaccines, necessitating recommendations for additional booster doses. However, longitudinal data reflecting
Externí odkaz:
https://doaj.org/article/e065b36ec6674ac794485395f839553b
Autor:
Hanna M. Ingelman-Sundberg, Lisa Blixt, David Wullimann, Jinghua Wu, Yu Gao, Katie Healy, Sandra Muschiol, Gordana Bogdanovic, Mikael Åberg, Christian Kjellander, Alba Grifoni, Alessandro Sette, Soo Aleman, Puran Chen, Ola Blennow, Lotta Hansson, Hans-Gustaf Ljunggren, Margaret Sällberg Chen, Marcus Buggert, Anders Österborg
Publikováno v:
Haematologica, Vol 109, Iss 2 (2023)
Externí odkaz:
https://doaj.org/article/9a1da4f8fd3c4dac915c990f5c17df64
Autor:
Carsten Niemann, Mark-David Levin, Anders Österborg, Jeanette Lundin, Magdalena Kättström, Jeanette Vollerup, Caspar Da Cunha-Bang, Michael Foraux, Christian Brieghel, Fransien de Boer, Lisbeth Enggaard, Christian Bjorn Poulsen, Joanne Reekie, Rudi Agius
Publikováno v:
HemaSphere, Vol 7, p e1432517 (2023)
Externí odkaz:
https://doaj.org/article/846c0a984fc74588a41972a7a107bbcc
Autor:
Maria Andersson, Tom Aadrian Mulder, Kia Heimersson, Sonja Sönnert-Husa, Annika Giertz, Lotta Hansson, Claes Karlsson, Jeanette Lundin, Anders Österborg, Marzia Palma
Publikováno v:
HemaSphere, Vol 7, p e18051e0 (2023)
Externí odkaz:
https://doaj.org/article/f6e4e8fe0b524982a996952075108d37
Autor:
Maria Andersson, Hemming Johansson, Anders Österborg, Agneta Månsson-Broberg, Lotta Hansson, Marzia Palma
Publikováno v:
HemaSphere, Vol 7, p e28011bd (2023)
Externí odkaz:
https://doaj.org/article/23d76477eef84b0387e4be7393b66b8d
Autor:
Puran Chen, Peter Bergman, Ola Blennow, Lotta Hansson, Stephan Mielke, Piotr Nowak, Gunnar Söderdahl, Anders Österborg, C.I. Edvard Smith, Jan Vesterbacka, David Wullimann, Angelica Cuapio, Mira Akber, Gordana Bogdanovic, Sandra Muschiol, Mikael Åberg, Karin Loré, Margaret Sällberg Chen, Marcus Buggert, Per Ljungman, Soo Aleman, Hans-Gustaf Ljunggren
Publikováno v:
EBioMedicine, Vol 94, Iss , Pp 104700- (2023)
Summary: Background: Immunocompromised patients have varying responses to SARS-CoV-2 mRNA vaccination. However, there is limited information available from prospective clinical trial cohorts with respect to long-term immunogenicity-related responses
Externí odkaz:
https://doaj.org/article/2329229490de4fbd80902984341b218f
Autor:
Angelica Cuapio, Caroline Boulouis, Iva Filipovic, David Wullimann, Tobias Kammann, Tiphaine Parrot, Puran Chen, Mira Akber, Yu Gao, Quirin Hammer, Benedikt Strunz, André Pérez Potti, Olga Rivera Ballesteros, Joshua Lange, Jagadeeswara Rao Muvva, Peter Bergman, Ola Blennow, Lotta Hansson, Stephan Mielke, Piotr Nowak, Gunnar Söderdahl, Anders Österborg, C. I. Edvard Smith, Gordana Bogdanovic, Sandra Muschiol, Fredrika Hellgren, Karin Loré, Michal J. Sobkowiak, Giorgio Gabarrini, Katie Healy, Margaret Sällberg Chen, Evren Alici, Niklas K. Björkström, Marcus Buggert, Per Ljungman, Johan K. Sandberg, Soo Aleman, Hans-Gustaf Ljunggren
Publikováno v:
Molecular Medicine, Vol 28, Iss 1, Pp 1-12 (2022)
Abstract Adaptive immune responses have been studied extensively in the course of mRNA vaccination against COVID-19. Considerably fewer studies have assessed the effects on innate immune cells. Here, we characterized NK cells in healthy individuals a
Externí odkaz:
https://doaj.org/article/385ad681ef5c4016a17b2e4b36257493
Autor:
Amineh Ghaderi, Mohammad‐Ali Okhovat, Layung Sekar Sih Wikanthi, Ann Svensson, Marzia Palma, Johan Schultz, Thomas Olin, Anders Österborg, Håkan Mellstedt, Mohammad Hojjat‐Farsangi
Publikováno v:
eJHaem, Vol 2, Iss 3, Pp 498-502 (2021)
Abstract ROR1 – a receptor tyrosine kinase – is overexpressed in CLL. Ibrutinib, a Bruton's tyrosine kinase inhibitor, is clinically effective in CLL but patients may develop resistance. We evaluated the effect of an ROR1 inhibitor, KAN0441571C,
Externí odkaz:
https://doaj.org/article/0aa8be017263486cb8f895e3be923506
Autor:
Jeanette Lundin, Tom A. Mulder, Magdalena Kättström, Tove Wästerlid, Anders Uddevik, Håkan Mellstedt, Kia Heimersson, Lotta Hansson, Marzia Palma, Anders Österborg
Publikováno v:
eJHaem, Vol 2, Iss 3, Pp 525-529 (2021)
Abstract Ibrutinib is used continuously in CLL. This phase 1b/2 study interim analysis explored on‐off‐repeat dosing to reduce toxicity. After 12 months, 16/22 patients (73%) remained in first off‐phase irrespective if initial CR/PR or TP53 abe
Externí odkaz:
https://doaj.org/article/7f328d6a737444259549a86a1865a7f1
Autor:
Amineh Ghaderi, Mohammad-Ali Okhovat, Jemina Lehto, Luigi De Petris, Ehsan Manouchehri Doulabi, Parviz Kokhaei, Wen Zhong, Georgios Z. Rassidakis, Elias Drakos, Ali Moshfegh, Johan Schultz, Thomas Olin, Anders Österborg, Håkan Mellstedt, Mohammad Hojjat-Farsangi
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1148 (2023)
The ROR1 receptor tyrosine kinase is expressed in embryonic tissues but is absent in normal adult tissues. ROR1 is of importance in oncogenesis and is overexpressed in several cancers, such as NSCLC. In this study, we evaluated ROR1 expression in NSC
Externí odkaz:
https://doaj.org/article/1287c54575b8479d88d0bd97b869a154